The LMAN1 gene helps move certain proteins, including clotting factors V and VIII, through cells so they can reach the bloodstream and support normal blood clotting. This gene plays an important role in how your body controls bleeding after a cut, dental work, or surgery. If the LMAN1 gene does not work properly, levels of these clotting factors can be low, causing combined factor V and factor VIII deficiency, with easy bruising, nosebleeds, heavy periods, or longer bleeding.
What is a gene?
Genes are segments of DNA with information that cells use to make molecules or regulate processes in the body. Some genes provide the instructions for making proteins, the working parts of cells. Others mainly control when certain processes happen, where they happen, and how strongly they take place. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To go further into this topic, you can find more in the LearnHub.
Overview
LMAN1Gene function
What if the gene works
The LMAN1 gene helps cells move certain proteins from the endoplasmic reticulum, where they are made, to the Golgi, where they are processed. This supports normal release of clotting factors, including factor V and factor VIII.
Risk
What if the gene does not work
Variants in the LMAN1 gene can cause combined factor V and factor VIII deficiency. People may bruise easily or bleed more with nosebleeds, surgery, injury, or periods. Milder and severe variants can affect when bleeding appears and severity.
Treatment
What does that mean for your treatment
With pathogenic variants in the LMAN1 gene, treatment decisions usually focus on boosting factor V and factor VIII levels before surgery, childbirth, or during bleeding. Fresh frozen plasma is commonly used, often with factor VIII concentrate, and desmopressin can help some people in milder situations. Day to day treatment is based on bleeding pattern rather than on a drug targeted to the LMAN1 gene itself.
Conditions associated with LMAN1
Gene function
What if the gene works
Inside your cells, the LMAN1 gene helps certain newly made proteins move through the cell's shipping system. This is part of how the LMAN1 gene helps move proteins from the endoplasmic reticulum, where proteins are made and folded, to the Golgi, where they are prepared for delivery. When this process runs smoothly, selected proteins can be processed and released in an organized way.
The protein made from the LMAN1 gene works like a cargo receptor, picking up selected proteins and helping them leave the endoplasmic reticulum. It guides them toward the Golgi so they can continue normal processing and packaging.
LMAN1 recognizes mannose rich sugar tags, which work like shipping labels on certain proteins. This helps the cell sort the right cargo for transport to the Golgi.
LMAN1 works with MCFD2, another transport helper, to carry a small set of important proteins through the cell's early export route. This includes support for the normal cell transport of clotting factors V and VIII.
After dropping off cargo, the LMAN1 protein returns to start the cycle again. This back and forth movement helps keep protein traffic steady between cell compartments.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions to a greater degree and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the LMAN1 gene can shorten the protein, stop it from being made, or change its shape so it becomes unstable and cannot work properly with MCFD2 to move clotting proteins through the cell. This helps explain how variants in the LMAN1 gene affect blood clotting protein transport. More disruptive variants often leave little or no working protein, while some milder missense variants keep partial activity. In LMAN1-related factor V and factor VIII deficiency, less remaining activity often matches lower factor levels and earlier or more noticeable bleeding.
How variants are linked to conditions
Pathogenic variants in the LMAN1 gene cause combined factor V and factor VIII deficiency, a rare inherited bleeding disorder. People with this LMAN1 gene bleeding disorder usually have two disease-causing variants, one inherited from each parent. The condition may lead to easy bruising, nosebleeds, heavy menstrual bleeding, or extra bleeding after injury, surgery, or dental work.
A variant is not necessarily a diagnosis
Genetic variants are a common and normal part of human biology. Most do not directly affect health and simply reflect natural variation among people. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when multiple genes and environmental factors contribute. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For LMAN1, the chance of having the related bleeding condition is mostly set by inheritance: it happens when a child receives a nonworking copy from both parents. In people living with this condition, bleeding can become more noticeable during surgery, dental work, injuries, or with blood-thinning medicines such as aspirin.
Inheritance of LMAN1 variants
For families asking how LMAN1 gene variants are inherited, the well established pattern is autosomal recessive. This means a person usually inherits one changed copy of the LMAN1 gene from each parent to have LMAN1-related factor V and factor VIII deficiency. Parents who each carry one variant are often unaffected, and with each pregnancy there is a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with two usual copies. This inheritance pattern applies equally to boys and girls.
What does my LMAN1 result mean for my family?
For LMAN1, family implications are usually tied to a rare bleeding condition called combined factor V and factor VIII deficiency, which runs in families in a recessive pattern. This often means parents are healthy carriers, brothers and sisters may also have the condition or be carriers, and other close relatives could carry the same gene change. Knowing the exact result can help clarify which family members might also want to learn their carrier status.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the LMAN1 gene, genetic testing for LMAN1 variants uses a blood or saliva sample to read the gene’s DNA sequence. Results may identify a known harmful variant, show no relevant variant, or find a variant whose meaning needs further interpretation.
When should I consider getting a genetic test?
Consider testing the LMAN1 gene if you or your child has unusual bleeding or easy bruising and blood tests show low levels of two clotting proteins, called factor V and factor VIII. Testing can also help when this condition runs in the family or when both parents are known carriers.
A genetic result is only one part of your health story
A genetic result can be helpful, but how much it reveals depends on the condition and on the specific type of variant. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is best considered together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or reacts to it at its target. This helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else. These differences are common and are one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way they respond to medicines. It studies links between genes and medications to help explain why the same treatment can work differently in different people. For many drugs, genes influence how strongly a medicine works or how the body handles it. This information can support treatment choices that are more informed and tailored to the individual. To explore this subject in more detail, more information is available in the LearnHub.
Drugs influenced by the LMAN1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about medicines, side effects, or changes in your health are best discussed with your doctor.
History
Combined factor V and factor VIII deficiency was recognized clinically long before its genetic cause was known. In the late 1990s, researchers identified the LMAN1 gene, also known in earlier laboratory work as ERGIC-53, as a key cause of this rare inherited bleeding condition. Initially understood only through visible traits, later recognized as tied to a specific gene, the condition became an important example of how genetic studies can clarify unusual bleeding patterns. Building on this early work, scientists uncovered more about the gene through studies in affected families from different parts of the world. These findings helped connect careful bedside observations with modern gene mapping. The way this gene was viewed has shifted over time, from a protein seen in cell transport research to a clearly established part of inherited bleeding genetics.